Sandu Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹38.47(3.44%)May 15, 2026 15:29:47 PM IST
- NSE
- BSE
- Vol : 0.98 K (NSE + BSE)Last 20 day avg : 7.82 K
Sandu Pharmaceuticals is trading 3.44% upper at Rs 38.47 as compared to its last closing price. Sandu Pharmaceuticals has been trading in the price range of 39.43 & 38.00. Sandu Pharmaceuticals has given -0.64% in this year & -7.09% in the last 5 days. Sandu Pharmaceuticals has TTM P/E ratio 16.77 as compared to the sector P/E of 48.14.The company posted a net profit of 0.04 Crores in its last quarter.Listed peers of Sandu Pharmaceuticals include Sun Pharmaceutical Industries (0.90%), Divi's Laboratories (-2.41%), Torrent Pharmaceuticals (-0.52%).The Mutual Fund holding in Sandu Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sandu Pharmaceuticals was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 17, 2026, 03:29 AM UTC
- BetaMedium volatility1.15Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.69Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.82The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values20.43Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation4.73The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,879.90 | 0.90 | 4,51,076.67 | 35.83 | 5.7 | 0.96 | 0.50 |
| Divi's Laboratories | Bullish | 6,755.00 | -2.41 | 1,78,679.99 | 72.02 | 10.56 | 0.50 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,386.00 | -0.52 | 1,48,148.92 | 71.89 | 18.26 | 0.85 | 17.62 |
| Lupin | Neutral | 2,273.90 | 0.71 | 1,04,095.41 | 31.35 | 6.09 | 0.52 | 11.80 |
| Dr Reddy's Laboratories | Bullish | 1,336.95 | 2.62 | 1,11,584.24 | 17.83 | 3.01 | 0.66 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE751D01014
- BSE Code524703
- NSE Code
Sandu Pharmaceuticals is trading at 38.47 as on Fri May 15 2026 09:59:47. This is 3.44% upper as compared to its previous closing price of 37.19.
The market capitalization of Sandu Pharmaceuticals is 36.37 Cr as on Fri May 15 2026 09:59:47.
The 52 wk high for Sandu Pharmaceuticals is 58.80 whereas the 52 wk low is 30.00
Sandu Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 16.77
- Sector P/E: 48.14
- Dividend Yield: 2.69%
- D/E ratio: 0.01
Sandu Pharmaceuticals reported a net profit of 1.77 Cr in 2026.
EQUITY QUICK LINKS
Sandu Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.